Francisco Javier Rupérez

Senior research scientist

Francisco Javier Rupérez

Francisco Javier Rupérez

Web of Science ResearcherID: https://publons.com/researcher/1382395/
Bio: Francisco Javier Rupérez is a Biochemist and currently Lecturer in Bioanalysis and related subjects at Universidad CEU San Pablo, Madrid (Spain). He holds a PhD in Pharmacy from Universidad CEU San Pablo and his research career continued as co-founder and active member of CEMBIO (Madrid, Spain). His experience as researcher and teacher has been developed over the past 23 years, counting with more than 60 publications in journals included in JCR. He has directed Master projects and PhD theses. He actively participates in competitive research projects and in different cooperation contracts with public entities and private companies. He is interested in all stages of the Metabolomics workflow, but specially focused in the methodology for LC/MS, as well as the biochemical interpretation. On top of all, he is strongly involved in the collaborative research characteristic of Metabolomics, because “Eowawa! THUS do we do in the CEMBIO!”.
Web of Science ResearcherID: I-8360-2012
ORCID: 0000-0001-6457-6234

Publications by Francisco Javier Rupérez:

Insulin Resistance in Obese Children: What Can Metabolomics and Adipokine Modelling Contribute?

Posted on: 29 Oct 2020

Dysregulation of glycerophospholipid metabolism during Behçet’s disease contributes to a pro-inflammatory phenotype of circulating monocytes

Posted on: 11 May 2020

Plasma Metabolic Signature of Atherosclerosis Progression and Colchicine Treatment in Rabbits

Posted on: 27 Abr 2020

Impact of global PTP1B deficiency on the gut barrier permeability during NASH in mice

Posted on: 06 Feb 2020

Metabolic impact of partial hepatectomy in the non-alcoholic steatohepatitis animal model of methionine-choline deficient diet

Posted on: 01 Nov 2019

Recent Developments along the Analytical Process for Metabolomics Workflows

Posted on: 18 Oct 2019

LAS: A Lipid Annotation Service Capable of Explaining the Annotations It Generates

Posted on: 30 Jul 2019

Insulin receptor substrate 2 (IRS2) deficiency delays liver fibrosis associated with cholestatic injury

Posted on: 16 Jul 2019

Microbiota Sensing by Mincle-Syk Axis in Dendritic Cells Regulates Interleukin-17 and -22 Production and Promotes Intestinal Barrier Integrity

Posted on: 19 Feb 2019

Differential Effects of a Glucagon-Like Peptide 1 Receptor Agonist in Non-Alcoholic Fatty Liver Disease and in Response to Hepatectomy

Posted on: 07 Nov 2018

Flow Cytometry Has a Significant Impact on the Cellular Metabolome

Posted on: 26 Oct 2018

Metabolomics changes in patients with PAPP-A2 deficiency in response to rhIGF1 treatment

Posted on: 12 Ago 2018


Posted on: 09 Jul 2018

Knowledge-based metabolite annotation tool: CEU Mass Mediator

Posted on: 30 May 2018

Stereochemical and structural effects of (2R,6R)-hydroxynorketamine on the mitochondrial metabolome in PC-12 cells

Posted on: 09 Mar 2018

Multiplatform plasma fingerprinting in cancer cachexia: a pilot observational and translational study

Posted on: 20 Feb 2018

Discriminant biomarkers of acute respiratory distress syndrome associated to H1N1 influenza identified by metabolomics HPLC-QTOF-MS/MS platform

Posted on: 17 Jul 2017

Metabolomics allows the discrimination of the pathophysiological relevance of hyperinsulinism in obese prepubertal children

Posted on: 07 Jun 2017

A metabolomic approach shows sphingosine 1-phosphate and lysophospholipids as mediators of the therapeutic effect of liver growth factor in emphysema

Posted on: 30 May 2017

A novel glucagon-like peptide 1/glucagon receptor dual agonist improves steatohepatitis and liver regeneration in mice

Posted on: 23 Nov 2016

Projects by Francisco Javier Rupérez:

Oops! There is nothing here.